Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21328246rdf:typepubmed:Citationlld:pubmed
pubmed-article:21328246lifeskim:mentionsumls-concept:C0042874lld:lifeskim
pubmed-article:21328246lifeskim:mentionsumls-concept:C0543891lld:lifeskim
pubmed-article:21328246pubmed:issue2lld:pubmed
pubmed-article:21328246pubmed:dateCreated2011-2-17lld:pubmed
pubmed-article:21328246pubmed:abstractTextAntipsychotic (neuroleptic) medication is used extensively to treat people with chronic mental illnesses. Its use, however, is associated with adverse effects, including movement disorders such as tardive dyskinesia (TD) - a problem often seen as repetitive involuntary movements around the mouth and face. Vitamin E has been proposed as a treatment to prevent or decrease TD.lld:pubmed
pubmed-article:21328246pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21328246pubmed:languageenglld:pubmed
pubmed-article:21328246pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21328246pubmed:citationSubsetIMlld:pubmed
pubmed-article:21328246pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21328246pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21328246pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21328246pubmed:statusMEDLINElld:pubmed
pubmed-article:21328246pubmed:issn1469-493Xlld:pubmed
pubmed-article:21328246pubmed:authorpubmed-author:McGrathJohnJlld:pubmed
pubmed-article:21328246pubmed:authorpubmed-author:Soares-Weiser...lld:pubmed
pubmed-article:21328246pubmed:authorpubmed-author:MaayanNicolaNlld:pubmed
pubmed-article:21328246pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21328246pubmed:ownerNLMlld:pubmed
pubmed-article:21328246pubmed:authorsCompleteYlld:pubmed
pubmed-article:21328246pubmed:paginationCD000209lld:pubmed
pubmed-article:21328246pubmed:dateRevised2011-6-16lld:pubmed
pubmed-article:21328246pubmed:meshHeadingpubmed-meshheading:21328246...lld:pubmed
pubmed-article:21328246pubmed:meshHeadingpubmed-meshheading:21328246...lld:pubmed
pubmed-article:21328246pubmed:meshHeadingpubmed-meshheading:21328246...lld:pubmed
pubmed-article:21328246pubmed:meshHeadingpubmed-meshheading:21328246...lld:pubmed
pubmed-article:21328246pubmed:meshHeadingpubmed-meshheading:21328246...lld:pubmed
pubmed-article:21328246pubmed:meshHeadingpubmed-meshheading:21328246...lld:pubmed
pubmed-article:21328246pubmed:meshHeadingpubmed-meshheading:21328246...lld:pubmed
pubmed-article:21328246pubmed:meshHeadingpubmed-meshheading:21328246...lld:pubmed
pubmed-article:21328246pubmed:year2011lld:pubmed
pubmed-article:21328246pubmed:articleTitleVitamin E for neuroleptic-induced tardive dyskinesia.lld:pubmed
pubmed-article:21328246pubmed:affiliationEnhance Reviews Ltd, John Eccles House, Robert Robinson Avenue, Oxford Science Park, Oxford, UK, OX4 4GP.lld:pubmed
pubmed-article:21328246pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21328246pubmed:publicationTypeReviewlld:pubmed
pubmed-article:21328246pubmed:publicationTypeMeta-Analysislld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:21328246lld:pubmed